These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6221535)

  • 21. The antiplatelet activity of immobilized prostacyclin.
    Ebert CD; Lee ES; Kim SW
    J Biomed Mater Res; 1982 Sep; 16(5):629-38. PubMed ID: 6752148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on structure-activity relationships of prostacyclin analogs based on molecular mechanics and molecular orbital methods.
    Miyamoto S; Yoshimoto M
    Chem Pharm Bull (Tokyo); 1987 Nov; 35(11):4510-6. PubMed ID: 3327624
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis of a highly potent analogue of prostacyclin, (-)-5-methyleneisocarbacyclin.
    Amemiya S; Koyama K; Saito S; Kojima K
    Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4403-5. PubMed ID: 3549013
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of prostacyclin analogues on platelet aggregation and blood pressure of anaesthetized beagle dogs.
    Hermán F; Hadházy P; Magyar K; Kovács G
    Prog Clin Biol Res; 1987; 242():101-6. PubMed ID: 3313407
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antiaggregation activity of various synthetic prostaglandins].
    Kudriashov SA; Geling NG; Mel'nikova VI; Pivnitskiĭ KK
    Biull Eksp Biol Med; 1982 Nov; 94(11):7-9. PubMed ID: 6758877
    [No Abstract]   [Full Text] [Related]  

  • 26. [Synthesis and antiaggregation activity of prostacyclin analogs. II. Direct synthesis of 15-fluoro-13,14-didehydrocarbacyclin].
    Lopp MI; Bergmann MA; Bezuglov VV; Vialimiaé TK; Lopp AKh
    Bioorg Khim; 1988 Jun; 14(6):834-8. PubMed ID: 3056417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis of a new chemically stable prostacyclin analogue with high and long-lasting activity.
    Iseki K; Kanayama T; Hayasi Y; Shibasaki M
    Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1769-71. PubMed ID: 2208396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasodilator and antiplatelet activities of prostacyclins with modified omega-side chain.
    Schölkens BA; Bartmann W; Beck G; Lerch U; Konz E; Weithmann U
    Adv Prostaglandin Thromboxane Res; 1980; 6():341-5. PubMed ID: 6992533
    [No Abstract]   [Full Text] [Related]  

  • 30. Synergism between prostacyclin (PGI2) and prazosin on human platelet aggregation.
    Moore PK
    Thromb Haemost; 1982 Feb; 47(1):76. PubMed ID: 7041326
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis of prostaglandin H2 (PGH2) and prostacyclin (PGI2) analogs: tetrathia-PGH2 and PGI2-ketal methyl ester.
    Nicolaou KC; Barnette WE; Magolda RL
    Prostaglandins Med; 1978 Jul; 1(1):96-7. PubMed ID: 362454
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of changes in dietary prostaglandin precursor fatty acids on arterial blood pressure and vascular prostacyclin synthesis.
    Düsing R; Scherhag R; Glänzer K; Budde U; Kramer HJ
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():209-15. PubMed ID: 6221595
    [No Abstract]   [Full Text] [Related]  

  • 33. Novel synthetic strategies for the preparation of prostacyclin and prostaglandin analogues--off the beaten track.
    Sheddan NA; Czybowski M; Mulzer J
    Chem Commun (Camb); 2007 Jun; (21):2107-20. PubMed ID: 17520108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociation between hemodynamic and platelet antiaggregant effects of prostacyclin in dogs determined with a rapid platelet isolation technique.
    Czer GT; Moser KM
    J Lab Clin Med; 1983 Jul; 102(1):133-9. PubMed ID: 6343535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboxane synthetase inhibition results in increased platelet sensitivity to prostacyclin.
    Bertelé V; Falanga A; Roncaglioni MC; Cerletti C; de Gaetano G
    Thromb Haemost; 1982 Jun; 47(3):294. PubMed ID: 7051411
    [No Abstract]   [Full Text] [Related]  

  • 36. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of conformationally restricted benzamidines as arginine surrogates in the design of platelet GPIIb-IIIa receptor antagonists.
    Sall DJ; Arfsten AE; Bastian JA; Denney ML; Harms CS; McCowan JR; Morin JM; Rose JW; Scarborough RM; Smyth MS; Um SL; Utterback BG; Vasileff RT; Wikel JH; Wyss VL; Jakubowski JA
    J Med Chem; 1997 Aug; 40(18):2843-57. PubMed ID: 9288166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 20-Methylprostacyclin: a powerful 'unnatural' platelet aggregation inhibitor.
    van Dorp DA; van Evert WC; van der Wolf L
    Prostaglandins; 1978 Dec; 16(6):953-5. PubMed ID: 373021
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
    Marmo E; Somma A; Ottavo R; Vairo G; Spaziante G; DiMezza F; Paone G
    J Med; 1981; 12(2-3):97-108. PubMed ID: 7024451
    [No Abstract]   [Full Text] [Related]  

  • 40. 6,9-thiaprostacyclin. A stable and biologically potent analogue of prostacyclin (PGI2).
    Nicolaou KC; Barnette WE; Gasic GP; Magolda RL
    J Am Chem Soc; 1977 Nov; 99(23):7736-8. PubMed ID: 334822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.